CREDIT SUISSE AG/ - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 78 filers reported holding UROGEN PHARMA LTD in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$14,850,600
+35.4%
1,060,0000.0%0.02%
+36.4%
Q2 2023$10,971,000
+12.0%
1,060,0000.0%0.01%
+10.0%
Q1 2023$9,794,400
+4.2%
1,060,0000.0%0.01%0.0%
Q4 2022$9,402,200
+6.6%
1,060,0000.0%0.01%0.0%
Q3 2022$8,819,000
+1.6%
1,060,000
-0.0%
0.01%
+11.1%
Q2 2022$8,681,000
-8.2%
1,060,010
-2.4%
0.01%
+12.5%
Q1 2022$9,456,000
-8.4%
1,085,521
-0.0%
0.01%
+60.0%
Q4 2021$10,326,000
-43.5%
1,085,749
+0.0%
0.01%
-50.0%
Q3 2021$18,260,000
+10.1%
1,085,671
-0.0%
0.01%
+11.1%
Q2 2021$16,581,000
-24.0%
1,085,868
-3.1%
0.01%
-18.2%
Q1 2021$21,831,000
+8.1%
1,120,711
-0.0%
0.01%
+10.0%
Q4 2020$20,202,000
-6.0%
1,121,071
+0.6%
0.01%
-23.1%
Q3 2020$21,494,000
-9.9%
1,114,283
+22.0%
0.01%
-23.5%
Q2 2020$23,852,000
+99.8%
913,178
+36.5%
0.02%
+70.0%
Q1 2020$11,935,000
-46.6%
669,003
-0.1%
0.01%
-37.5%
Q4 2019$22,339,000
+46.6%
669,435
+4.7%
0.02%
+23.1%
Q3 2019$15,239,000
-25.9%
639,461
+11.7%
0.01%
-27.8%
Q2 2019$20,577,000
+8.0%
572,562
+11.0%
0.02%
+5.9%
Q1 2019$19,047,000
+1.3%
515,609
+18.1%
0.02%
-15.0%
Q4 2018$18,800,000
-5.2%
436,576
+4.0%
0.02%
+11.1%
Q3 2018$19,828,000
+45.3%
419,828
+53.1%
0.02%
+38.5%
Q2 2018$13,644,000
-22.0%
274,201
-22.1%
0.01%
-18.8%
Q1 2018$17,491,000
+109.9%
352,000
+57.1%
0.02%
+128.6%
Q4 2017$8,335,000
+164.4%
224,000
+124.0%
0.01%
+133.3%
Q3 2017$3,152,000100,0000.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders